Tag: Study

Kroger Health’s Food as Medicine Platform Recognized as a Leading Healthy Lifestyle Approach by University of Cincinnati Study
Newly released “Supermarket and Website-centered Intervention focusing on Nutrition” analyze validates good impact of retail-based nutritional interventions

CINCINNATI, April 4, 2022 /PRNewswire/ — Kroger Overall health, the healthcare division of The Kroger Co. (NYSE: KR), funded the College of Cincinnati to execute an impartial clinical study analyze to understand how stores, like Kroger, serve as an critical healthcare spot by leveraging foods and nutrition schooling to guidance the wellness and wellbeing of customers. The study, Supermarket and World-wide-web-centered Intervention focusing on Nourishment (SuperWIN), was a groundbreaking, randomized controlled trial aimed at raising diet quality and reducing cardiovascular chance by selling a coronary heart-healthful food plan by means of nutrition counseling presented by a registered dietitian.

Kroger Overall health (PRNewsfoto/The Kroger Co.)

“We have normally considered in the electricity of Meals as Medicine in taking care of and protecting against disease ahead of it begins,” says Colleen Lindholz, president, Kroger Overall health. “The SuperWIN examine presents true planet evidence that our dietitians can help consumers take in better and dwell healthier life by use of technology, training, and procuring equipment.”

Vital Findings:
The study final results declared at the American College of Cardiology’s Annual Scientific Session & Expo held on April 3, 2022, in Washington, D.C. present that:
- In-aisle training with a Kroger Health and fitness registered dietitian noticeably greater adherence to a coronary heart-healthier dietary pattern when compared to classic nourishment counseling on your own. Adherence was further more enhanced when in-aisle educating was paired with education on how to use on-line buying technologies, together with grocery supply company, the Kroger application and web page, and OptUP, Kroger Health’s marketplace-leading nutrition rating process to simplify and monitor much healthier searching.
- Vendors like Kroger provide as an essential health care vacation spot, aligning with a short while ago surveyed customers who determined their major foods merchants (48{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}) as institutions aiding them remain healthful.
“SuperWIN is probably the most scientifically rigorous research of a detailed health care intervention at any time executed with the retail field,” claims Dylan Steen, MD, of the Division of Cardiovascular Overall health and Disorder at the UC College or university of Medicine. “In terms of buying facts, suppliers have been collecting these info for decades. These information are now progressively staying connected to nutrition facts and hence could be employed by dietitians, nurses, pharmacists, and doctors to give the very best, individualized steerage to sufferers.”

“Kroger Well being is very pleased of our partnership with the University of Cincinnati and the SuperWIN demo,” states Bridget Wojciak, Director of Diet, Kroger Wellbeing. “We are striving every working day to elevate the grocery shop as a desired destination for preventive health care. Our Food items as Drugs technique is a dedicated, educated, and personalised method to taking in and experiencing meals to protect against sickness just before it starts, and this research has shown that our method operates.”

The SuperWIN demo is the hottest evidence supporting Kroger’s Foods as Medication system and the worth of registered dietitians, the nation’s foremost professionals in diet, offering the public with proof-based mostly diet care. Kroger has considering the fact that expanded accessibility to nutrition treatment by means of its telenutrition program, supplying two-way video chat appointments with Kroger Overall health registered dietitians across the state.

To down load the SuperWIN report, go to listed here.

About Kroger Health and fitness:
Kroger Health, the healthcare division of The Kroger Co., is 1 of America’s top retail healthcare companies, with more than 2,200 pharmacies and 220 clinics in 35 states serving additional than 14 million consumers. Our crew of 22,000 healthcare practitioners – from pharmacists and nurse practitioners, to dietitians and specialists – are fully commited to helping people are living healthier lives. We feel in practising at the top of our licenses and enabling “food as drugs” to support prevent or take care of particular disorders. We are dedicated to supplying testing and wellness providers to assistance Us citizens battle the COVID-19 disaster.

About Kroger:
At The Kroger Co. (NYSE: KR), we are focused to our Objective: to Feed the Human Spirit™. We are, across our relatives of organizations, almost fifty percent a million associates who serve over nine million customers each day by means of a seamless digital browsing experience and 2,800 retail food items suppliers under a range of banner names, serving America via food stuff inspiration and uplift, and producing #ZeroHungerZeroWaste communities by 2025. To understand much more about us, take a look at our newsroom and trader relations internet site.

Cision

See initial content material to download multimedia:https://www.prnewswire.com/news-releases/kroger-healths-food-as-medication-system-identified-as-a-primary-wholesome-way of living-tactic-by-university-of-cincinnati-study-301516677.html

Source The Kroger Co.
April 5, 2022
CBD and THC may be safe for use with opioid pain relievers, animal study suggests

Conclusions from a new animal examine counsel that cannabidiol (CBD) and tetrahydrocannabinol (THC) may possibly be harmless for use with opioid discomfort relievers. Despite the fact that much more experiments are necessary, the outcomes propose that these compounds may possibly be a small-possibility way to cut down the dose of opioids needed to relieve ache.

&#13

There is intense fascination in making use of health-related marijuana in clients with chronic suffering because compounds in marijuana like CBD and THC may perhaps create discomfort aid by themselves or enrich the suffering-relieving outcomes of opioids. This implies men and women could most likely use reduce doses of opioids and continue to get aid from agony. Getting much less soreness medication could also lead to a decreased hazard of addiction or physical dependence to opioids.”

&#13
&#13

Lawrence Carey, PhD, postdoctoral fellow, College of Texas Health and fitness Science Middle, San Antonio

&#13

The researchers uncovered that CBD and THC do not boost the worthwhile consequences of opioids. This signifies that these compounds may not maximize the threat for addiction when utilised in conjunction with opioids.

Carey will present the new analysis at the American Society for Pharmacology and Experimental Therapeutics annual conference in the course of the Experimental Biology (EB) 2022 assembly, to be held April 2–5 in Philadelphia.

In the new study, the scientists gave rhesus monkeys the prospect to opt for a meals reward or an injection of the opioid fentanyl. They then examined regardless of whether CBD, THC or mixtures that contains equally compounds afflicted the variety of situations monkeys picked fentanyl over foodstuff. They uncovered that a huge range of doses of CBD or THC both of those on your own or in a mixture did not improve or lessen the quantity of times they picked fentanyl.

“Offering the animals the opportunity to pick out concerning a drug injection and a foodstuff reward served us to relatively replicate options a human drug consumer may encounter, these as whether or not to expend funds on medications or meals,” stated Carey. “Getting the possibility of responding for food is also practical for learning prescription drugs like THC that generate sedative outcomes. It will help exhibit the animal is reallocating conduct from drug to foods selection rather of merely shutting down reaction for a drug because of to sedation.”

The researchers are now conducting other studies to evaluate whether CBD and THC can minimize indicators of opioid withdrawal and relapse.

“A massive reason why folks keep on to just take opioids right after they grow to be addicted is the look of withdrawal symptoms,” claimed Carey. “We are employing what we uncovered from this examine to ascertain regardless of whether these doses – which didn’t alter alternative for food items or drug benefits – may well aid relieve opioid withdrawal or lower relapse and drug in search of conduct next periods of abstinence.”

The scientists caution that opioid use problem is a complicated disorder and there are numerous aspects to look at when developing a drug to handle it. Despite the fact that this examine suggests that THC and CBD do not improve the satisfying effects of opioids, they say that prior to making use of these results to individuals, it will be essential to decide no matter whether these remedies change other pathological procedures concerned with opioid use and to better comprehend any dangers that may possibly be related with their use.

Lawrence Carey will present this investigate from 10 a.m.–12 p.m., Monday, April 4, in Exhibit/Poster Hall A-B, Pennsylvania Convention Centre (Poster Board Amount B12) (summary) and 1:43–1:56 p.m., April 4 in Space 113 A (summary). Get in touch with the media crew for a lot more info or to attain a cost-free push pass to attend the assembly.

April 5, 2022
Ivermectin Does Not Reduce Risk of Covid Hospitalization, Large Study Finds

The anti-parasitic drug ivermectin, which has surged in attractiveness as an different treatment method for Covid-19 irrespective of a lack of robust investigation to again it up, showed no indicator of assuaging the disease, in accordance to effects of a significant scientific demo printed on Wednesday.

The examine, which compared additional than 1,300 persons contaminated with the coronavirus in Brazil who gained either ivermectin or a placebo, properly dominated out the drug as a cure for Covid, the study’s authors said.

“There’s truly no indication of any gain,” claimed Dr. David Boulware, an infectious-illness expert at the University of Minnesota.

The scientists shared a summary of these success in August in the course of an on the web presentation hosted by the Nationwide Institutes of Wellbeing, but the whole facts established had not been posted until finally now in The New England Journal of Drugs.

“Now that men and women can dive into the particulars and the facts, with any luck , that will steer the greater part of physicians away from ivermectin in the direction of other therapies,” Dr. Boulware reported.

For decades, ivermectin has been widely utilised to handle parasitic bacterial infections. Early in the pandemic, when researchers ended up making an attempt 1000’s of old medicine towards Covid-19, laboratory experiments on cells recommended that ivermectin might block the coronavirus.

At the time, skeptics pointed out that the experiments worked many thanks to substantial concentrations of the drug — considerably past safe and sound levels for people today. However, some medical practitioners commenced prescribing ivermectin for Covid-19, in spite of a warning from the Food and Drug Administration that it was not accredited for these types of use.

About the planet, scientists carried out tiny medical trials to see if the drug treated the ailment. In December 2020, Andrew Hill, a virologist at the College of Liverpool in England, reviewed the outcomes of 23 trials and concluded that ivermectin appeared to considerably reduced the threat of death from Covid-19.

If larger trials confirmed individuals conclusions, Dr. Hill said in a presentation at the time, “this truly is going to be a transformative treatment method.”

Ivermectin’s level of popularity continued to climb in the pandemic’s second yr. The podcaster Joe Rogan promoted it repeatedly on his reveals. In a solitary week in August, U.S. insurance policies companies used $2.4 million spending for ivermectin treatment options

But not lengthy following Dr. Hill revealed his overview very last summer, stories surfaced that many of the scientific tests he bundled in the assessment were being flawed and, in at the very least 1 scenario, alleged to be fraudulent. Dr. Hill retracted his primary review and started out a new just one, which he revealed in January.

Updated

April 4, 2022, 8:16 a.m. ET

On their next overview, Dr. Hill and his colleagues centered on the studies minimum very likely to be biased. In that stricter study, ivermectin’s profit vanished.

Nevertheless, even the very best research on ivermectin and Covid were compact, with a couple of hundred volunteers at most. Modest experiments can be vulnerable to statistical flukes that propose optimistic outcomes exactly where none really exist. But larger sized studies on ivermectin had been underway at the time, and those promised to be extra rigorous.

In Brazil, researchers established up a medical trial recognized as Together in June 2020 to check Covid clients with a amount of greatly applied drugs, like ivermectin. The treatment plans ended up double-blinded, indicating that neither the individuals nor their clinical staff members realized no matter whether they been given a Covid procedure drug or a placebo.

In just one spherical of the demo, the scientists discovered promising proof that an antidepressant drug referred to as fluvoxamine decreased the will need for hospitalization by one particular-3rd. The scientists published their success in October in The Lancet World wide Overall health.

In a new analyze released on Wednesday, the Alongside one another group noted on its ivermectin facts. Involving March and August 2021, the researchers presented the drug to 679 sufferers around the system of a few days.

The outcomes were being crystal clear: Taking ivermectin did not cut down a Covid patient’s danger of ending up in the healthcare facility.

The researchers zeroed in on distinct groups of volunteers to see if they skilled added benefits that other people didn’t. For case in point, it could possibly be attainable that ivermectin only labored if taken early in an infection. But volunteers who took ivermectin in the 1st 3 times after the onset of Covid signs and symptoms turned out to have even worse outcomes than did people in the placebo group.

Dr. Hill was impressed with the success. “They have run a significant-excellent, placebo-managed trial,” he explained. He also expressed impatience with the New England Journal of Medicine for taking months to publish the outcomes: “I really do not understand the hold off with this trial from NEJM.”

Julia Morin, a spokeswoman for the journal, declined to remark on the hold off. “We really do not remark on the editorial course of action, as it’s private,” she mentioned in an e mail.

Dr. Hill has run his assessment of ivermectin experiments once again, this time which include the new data from the Together trial. All explained to, his investigation incorporated far more than 5,000 individuals. And after additional, he saw no profit from ivermectin.

Continue to, there are various ongoing randomized trials of ivermectin, with thousands of volunteers, that have but to share their final results. The Nationwide Heart for Advancing Translational Sciences, which is element of the N.I.H., has for much more than a calendar year been functioning a single carefully viewed trial of ivermectin and various other medication for Covid people. But it has but to release success.

Dr. Sarah Dunsmore, a program director in the medical innovations division at NCATS, mentioned that scientists were being examining the first batch of effects on ivermectin and would launch them in two to 3 months.

Dr. Boulware doubted that the supplemental trials would occur to a distinctive summary, since the Together demo was so large and carefully developed. “Rarely would you expect to uncover something different,” he said.

Dr. Paul Sax, an infectious-ailment expert at Brigham and Women’s Healthcare facility in Boston who was not included in the Together demo, shared Dr. Boulware’s perspective.

“I welcome the benefits of the other medical trials and will look at them with an open up head, but at some stage it will turn out to be a squander of assets to proceed studying an unpromising approach,” he reported.

April 4, 2022
Traditional Chinese medicine, Shengmai Yin, improves the effects of radiation therapy, says new study

Analysis reveals standard Chinese medication Shengmai Yin, designed from ginseng and other herbs, might assist the radiotherapy for nasopharyngeal carcinoma by rendering cells extra delicate to radiation. Credit history: Eugene Kim below CC BY 2.

Cure of nasopharyngeal carcinoma (NPC), a team of cancers that originate in the nose and throat, is manufactured complicated by their exclusive posture. Radiation treatment is typically the principal curative therapy for NPC. Nevertheless, some patients are resistant to radiation therapy. Investigation has advised that a phenomenon termed ‘DNA methylation’ has a main influence on radioresistance.

Radioresistance can be mitigated by the use of ‘radiosensitizers,’ chemical compounds that make cells a lot more vulnerable to radiation. Lately, a team of researchers led by Dr. Qin Admirer of Southern Clinical College and Dr. Ying Lv of NanFang Clinic, China have discovered Shengmai Yin (SMY), a regular organic drugs, as an powerful radiosensitizer for patients with NPC. The paper was created obtainable online on 2nd December 2020 and was revealed in Quantity 11 Challenge 6 of the Journal of Pharmaceutical Evaluation in December 2021.

“DNA methylation is an epigenetic improve, which usually means that it is brought on by a improve in how the genes are expressed instead than a mutation in the genetic code. As a consequence, epigenetic adjustments are reversible and can usually be modulated by phytochemicals. Getting a cue from before research, we investigated if SMY can alter DNA methylation standing in NPC cells and no matter if these changes motivated the radiosensitivity of the cells,” describes Dr. Admirer.

For their research, the scientists very first compared the DNA methylation concentrations in two different cell traces of NPC, radiosensitive NPC cells CNE-2 and radioresistant NPC cells CNE-2R. The CNE-2R cells at first experienced decreased ranges of methylated genes than the CNE-2 cells. On the other hand, right after dealing with the CNE-2R cells with SMY, the scientists located that the methylation of some of these genes was restored. A single of these genes was a single that encodes Tenascin-C (TNC), a glycoprotein that is concerned in several mobile procedures, including the invasion, invasiveness, and migration of tumor cells. Past studies have proven that lessening the methylation of the ‘promoter’ location of this gene raises the expression of TNC.

Study reveals regular Chinese medication Shengmai Yin, designed from codonopsis (Dang shen) and other herbs, may perhaps support the radiotherapy for nasopharyngeal carcinoma by rendering cells a lot more delicate to radiation. Credit history: ProjectManhattan below CC BY-SA 3.

The exploration workforce in contrast the expression of TNC in each mobile traces and identified that it was overexpressed in CNE-2R cells. They then identified that SMY minimized the creation of TNC in most cancers cells. “We speculated that this could be due to the restoration of the methylation position of TNC by SMY. We later on confirmed our hypothesis. Our scientific tests propose that SMY contributes to the methylation of sure promoter areas of the TNC gene known as CpG web-sites. When a protein identified as specificity protein 1 (SP1) binds to methylated CpG web sites, it inhibits the expression of TNC, ” states Dr. Lover.

The findings of the examine drop gentle on 3 incredibly significant elements of SMY as a therapeutic complement all through radiotherapy. Dr. Lv elaborates ”First, moreover minimizing the aspect effects of radiation, it can enhance the efficacy of radiotherapy and decrease the facet effects of radiotherapy in NPC next, SMY, because of its anti-tumorigenic effect, can provide as a preventive complement for a neighborhood that constantly relied on the healing electrical power of traditional medication. Third, SMY offers an alternate for acquiring a value-powerful ‘radiosensitizer’ for the pharmaceutical industry.”

SMY has the possible to be a risk-free, efficient and economically feasible radiosensitizer and therapeutic health supplement to radiation therapy. Acquiring prescription drugs dependent on this conventional Chinese medicine could enable make improvements to the high-quality of existence and cut down the mortality of sufferers with NPC.

How oral most cancers acquires radioresistance

Extra information and facts:
Shiya Liu et al, Result of Shengmai Yin on the DNA methylation status of nasopharyngeal carcinoma mobile and its radioresistant strains, Journal of Pharmaceutical Investigation (2020). DOI: 10.1016/j.jpha.2020.11.010

Delivered by
Cactus Communications

Citation:
Traditional Chinese medication, Shengmai Yin, improves the outcomes of radiation remedy, suggests new study (2022, February 25)
retrieved 26 February 2022
from https://medicalxpress.com/news/2022-02-classic-chinese-medication-shengmai-yin.html

This doc is subject matter to copyright. Apart from any truthful working for the objective of non-public review or investigation, no
element may perhaps be reproduced with no the penned authorization. The content is presented for information and facts functions only.

February 26, 2022
Allied health and complementary therapy usage in Australian women with chronic pelvic pain: a cross-sectional study | BMC Women’s Health
Daniels JP, Khan KS. Chronic pelvic pain in women. BMJ. 2010;341:c4834.

Article

Google Scholar
Patnaik SS, Laganà AS, Vitale SG, Butticè S, Noventa M, Gizzo S, Valenti G, Rapisarda AMC, La Rosa VL, Magno C, et al. Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. Arch Gynecol Obstet. 2017;295(6):1341–59.

CAS
Article

Google Scholar
Ahangari A. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician. 2014;17(2):E141-147.

Article

Google Scholar
EAU Guidelines on Chronic Pelvic Pain. https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Chronic-Pelvic-Pain-2020.pdf.
Rowlands IJ, Abbott JA, Montgomery GW, Hockey R, Rogers P, Mishra GD. Prevalence and incidence of endometriosis in Australian women: a data linkage cohort study. BJOG. 2021;128(4):657–65.

CAS
Article

Google Scholar
Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019;15(11):666–82.

Article

Google Scholar
Armour M, Sinclair J, Ng CHM, Hyman MS, Lawson K, Smith CA, Abbott J. Endometriosis and chronic pelvic pain have similar impact on women, but time to diagnosis is decreasing: an Australian survey. Sci Rep. 2020;10(1):16253.

CAS
Article

Google Scholar
Armour M, Lawson K, Wood A, Smith CA, Abbott J. The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: a national online survey. PLoS ONE. 2019;14(10):e0223316.

CAS
Article

Google Scholar
Armour M, Ciccia D, Stoikos C, Wardle J. Endometriosis and the workplace: lessons from Australia’s response to COVID-19. Aust N Z J Obstet Gynaecol. 2021. https://doi.org/10.1111/ajo.13458.
Laganà AS, Condemi I, Retto G, Muscatello MR, Bruno A, Zoccali RA, Triolo O, Cedro C. Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2015;194:30–3.

Article

Google Scholar
Laganà AS, La Rosa VL, Rapisarda AMC, Valenti G, Sapia F, Chiofalo B, Rossetti D, Ban Frangež H, Vrtačnik Bokal E, Vitale SG. Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Womens Health. 2017;9:323–30.

Article

Google Scholar
D’Alterio MN, Saponara S, Agus M, Laganà AS, Noventa M, Loi ES, Feki A, Angioni S. Medical and surgical interventions to improve the quality of life for endometriosis patients: a systematic review. Gynecol Surg. 2021;18(1):13.

Article

Google Scholar
Rowe HJ, Hammarberg K, Dwyer S, Camilleri R, Fisher JRW. Improving clinical care for women with endometriosis: qualitative analysis of women’s and health professionals’ views. J Psychosom Obstet Gynecol. 2019;42:174–80.

Article

Google Scholar
O’Hara R, Rowe H, Fisher J. Managing endometriosis: a cross-sectional survey of women in Australia. J Psychosom Obstet Gynaecol. 2020.
https://doi.org/10.1080/0167482X.2020.1825374
Lukas I, Kohl-Schwartz A, Geraedts K, Rauchfuss M, Wölfler MM, Häberlin F, von Stephanie O, Eberhard M, Imthurn B, Imesch P, et al. Satisfaction with medical support in women with endometriosis. PLoS ONE. 2018;13(11):e0208023.

Article

Google Scholar
Fisher C, Adams J, Hickman L, Sibbritt D. The use of complementary and alternative medicine by 7427 Australian women with cyclic perimenstrual pain and discomfort: a cross-sectional study. BMC Complement Altern Med. 2016;16:129.

Article

Google Scholar
Chronic Disease Management (formerly Enhanced Primary Care or EPC). https://www1.health.gov.au/internet/main/publishing.nsf/Content/mbsprimarycare-chronicdiseasemanagement.
Armour M, Ferfolja T, Curry C, Hyman MS, Parry K, Chalmers KJ, Smith CA, MacMillan F, Holmes K. The prevalence and educational impact of pelvic and menstrual pain in Australia: A national online survey of 4202 young women aged 13–25 years. J Pediatr Adolesc Gynecol. 2020;33(5):511–8.

Article

Google Scholar
National Statement on Ethical Conduct in Human Research 2007 (Updated 2018). www.nhmrc.gov.au/guidelines/publications/e72.
Simoens S, Hummelshoj L, Dunselman G, Brandes I, Dirksen C, D’Hooghe T, EndoCost C. Endometriosis cost assessment (the EndoCost study): a cost-of-illness study protocol. Gynecol Obstet Invest. 2011;71(3):170–6.

Article

Google Scholar
1249.0 – Australian Standard Classification of Cultural and Ethnic Groups (ASCCEG). http://www.abs.gov.au/ausstats/[email protected]/mf/1249.0.
Steel A, McIntyre E, Harnett J, Foley H, Adams J, Sibbritt D, Wardle J, Frawley J. Complementary medicine use in the Australian population: results of a nationally-representative cross-sectional survey. Sci Rep. 2018;8(1):17325.

Article

Google Scholar
Pledger MJ, Cumming JN, Burnette M. Health service use amongst users of complementary and alternative medicine. N Z Med J. 2010;123(1312):26–35.

PubMed

Google Scholar
Young K, Fisher J, Kirkman M. Women’s experiences of endometriosis: a systematic review and synthesis of qualitative research. J Fam Plan Reprod Health Care. 2015;41(3):225.

Article

Google Scholar
Roomaney R, Kagee A. Coping strategies employed by women with endometriosis in a public health-care setting. J Health Psychol. 2015;21(10):2259–68.

Article

Google Scholar
Grundström H, Kjølhede P, Berterö C, Alehagen S. “A challenge”—healthcare professionals’ experiences when meeting women with symptoms that might indicate endometriosis. Sex Reprod Healthc. 2016;7:65–9.

Article

Google Scholar
Young K, Fisher J, Kirkman M. Clinicians’ perceptions of women’s experiences of endometriosis and of psychosocial care for endometriosis. Aust N Z J Obstet Gynaecol. 2017;57(1):87–92.

Article

Google Scholar
Young K, Fisher J, Kirkman M. Women’s experiences of endometriosis: a systematic review and synthesis of qualitative research. J Fam Plan Reprod Health Care. 2015;41(3):225–34.

Article

Google Scholar
Cant RP, Foster MM. Investing in big ideas: utilisation and cost of Medicare Allied Health services in Australia under the Chronic Disease Management initiative in primary care. Aust Health Rev. 2011;35(4):468–74.

Article

Google Scholar
Fuentes-Márquez P, Cabrera-Martos I, Valenza MC. Physiotherapy interventions for patients with chronic pelvic pain: a systematic review of the literature. Physiother Theory Pract. 2019;35(12):1131–8.

Article

Google Scholar
Lund I, Lundeberg T. Is acupuncture effective in the treatment of pain in endometriosis? J Pain Res. 2016;9:157–65.

Article

Google Scholar
Hansen KE, Kesmodel US, Kold M, Forman A. Long-term effects of mindfulness-based psychological intervention for coping with pain in endometriosis: a six-year follow-up on a pilot study. Nordic Psychol. 2017;69(2):100–9.

Article

Google Scholar
Huijs E, Nap A. The effects of nutrients on symptoms in women with endometriosis: a systematic review. Reprod Biomed Online. 2020;41(2):317–28.

CAS
Article

Google Scholar
National Action Plan for Endometriosis. http://www.health.gov.au/internet/main/publishing.nsf/Content/endometriosis.
Facchin F, Barbara G, Saita E, Mosconi P, Roberto A, Fedele L, Vercellini P. Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynecol. 2015;36(4):135–41.

Article

Google Scholar
Di Donato N, Montanari G, Benfenati A, Monti G, Leonardi D, Bertoldo V, Facchini C, Raimondo D, Villa G, Seracchioli R. Sexual function in women undergoing surgery for deep infiltrating endometriosis: a comparison with healthy women. J Fam Plan Reprod Health Care. 2015;41(4):278–83.

Article

Google Scholar
Cervigni M, Natale F. Gynecological disorders in bladder pain syndrome/interstitial cystitis patients. Int J Urol. 2014;21(Suppl 1):85–8.

Article

Google Scholar
Tirlapur SA, Kuhrt K, Chaliha C, Ball E, Meads C, Khan KS. The “evil twin syndrome” in chronic pelvic pain: a systematic review of prevalence studies of bladder pain syndrome and endometriosis. Int J Surg. 2013;11(3):233–7.

CAS
Article

Google Scholar
Spinks J, Hollingsworth B. Policy Implications of Complementary and Alternative Medicine Use in Australia: data from the National Health Survey. J Altern Complem Med. 2012;18(4):371–8.

Article

Google Scholar
Reid R, Steel A, Wardle J, Trubody A, Adams J. Complementary medicine use by the Australian population: a critical mixed studies systematic review of utilisation, perceptions and factors associated with use. BMC Complem Altern Med. 2016;16(1):176.

Article

Google Scholar
Schwartz ASK, Gross E, Geraedts K, Rauchfuss M, Wölfler MM, Häberlin F, von Orelli S, Eberhard M, Imesch P, Imthurn B, et al. The use of home remedies and complementary health approaches in endometriosis. Reprod Biomed Online. 2019;38(2):260–71.

Article

Google Scholar
Chen L, Michalsen A. Management of chronic pain using complementary and integrative medicine. BMJ. 2017;357:j1284.

Article

Google Scholar
Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, Brodszky V, Canis M, Colombo GL, DeLeire T, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012;27(5):1292–9.

Article

Google Scholar
Shafrir AL, Wise LA, Palmer JR, Shuaib ZO, Katuska LM, Vinayak P, Kvaskoff M, Terry KL, Missmer SA. Validity of self-reported endometriosis: a comparison across four cohorts. Hum Reprod. 2021;36(5):1268–78.

CAS
Article

Google Scholar